H.R. 2004 · 119th Congress · Health
Tyler’s Law
Requires HHS to study fentanyl testing in hospital emergency departments and issue guidance. AI-read
- IntroducedMar 10, 2025 Done
- CommitteeReported Sep 14, 2026 Done
- House floorPassed by voice vote · Sep 15, 2026 Done
- Senate floorAwaiting vote Current stage
- Chambers agreeNot yet Not reached yet
- PresidentNot yet Not reached yet
What it does
This bill requires the Department of Health and Human Services (HHS) to complete, within one year after the bill’s enactment, a study on how frequently Medicare-participating hospital emergency departments test for fentanyl in patients experiencing an overdose, the costs associated with such testing, and how such testing may impact patients.
Within six months after the study’s completion and based on its results, HHS must issue guidance regarding (1) whether hospital emergency departments should implement fentanyl testing as a routine procedure for patients experiencing an overdose, (2) how to ensure clinicians know which substances they are testing for in routine drug tests, and (3) how fentanyl testing may affect the future risk of overdose and other health outcomes.
Congressional Research Service · summary of “Introduced in House” version · Mar 10, 2025
Who lobbies on it
4 organizations · 11 filings, incl. 1 naming only S. 921 · Q1 2025–Q3 2026One square per quarter since introduction, oldest left. Filled = named H.R. 2004 or S. 921 that quarter.
-
American College of Emergency Physicians
7 of 7 quarters
“Opioids, pain management Federal funding for substance use disorder treatments H.R.2004-Tylers Law, to direct the Secretary of Health and Human Services to issue guidance on whether hospital emergency departments should implement routine fentanyl testing for patients experiencing an overdose H.R. 2483-Support for…”
-
American Society of Health-System Pharmacists
2 of 7 quarters
“Issues related to vaccine access and evidence-based resources for patients and pharmacists (generally, no specific legislation). Tylers Law (H.R. 2004), the ALERT Communities Act (H.R. 1561), and the HERO Act (H.R. 7994), issues related to access to fentanyl test strips and medications for opioid use disorder (MOUD).…”
-
American Medical Association
1 of 7 quarters
“H.R.1266 - Combating Illicit Xylazine Act, all provisions H.R.1561 - ALERT Communities Act, all provisions H.R.2004 - Tylers Law, all provisions H.R.7970 - STOP Nitazenes Act, all provisions H.R.7994 - HERO Act, all provisions Comment Letter: [2026-11602] HHS Request for Comment on Chronic Disease of Addiction Chronic…”
1 more organization, every filingPROUpgrade
Organizations that named H.R. 2004 or its companion S. 921 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. Reports naming only S. 921 are included and tagged. Source: Senate lobbying disclosures (LD-2) from lda.gov; quotes are word for word from the “specific lobbying issues” field.
Actions
17 actions · newest first- Sep 16, 2026Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 625.
- Sep 15, 2026Motion to reconsider laid on the table Agreed to without objection.
- Sep 15, 2026On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H5673)
- Sep 15, 2026Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.
Show all 17 actionsShow fewer
- Sep 15, 2026DEBATE - The House proceeded with forty minutes of debate on H.R. 2004.
- Sep 15, 2026Considered under suspension of the rules. (consideration: CR H5673-5674)
- Sep 15, 2026Mr. Guthrie moved to suspend the rules and pass the bill.
- Sep 14, 2026Placed on the Union Calendar, Calendar No. 716.
- Sep 14, 2026Reported by the Committee on Energy and Commerce. H. Rept. 119-817.
- Jul 21, 2026Ordered to be Reported by the Yeas and Nays: 46 - 0.
- Jul 21, 2026Committee Consideration and Mark-up Session Held
- Jul 20, 2026Committee Consideration and Mark-up Session Held
- Jun 25, 2026Forwarded by Subcommittee to Full Committee by Voice Vote.
- Jun 25, 2026Subcommittee Consideration and Mark-up Session Held
- Mar 10, 2025Referred to the House Committee on Energy and Commerce.
- Mar 10, 2025Referred to the Subcommittee on Health.
- Mar 10, 2025Introduced in House
What members said about it
On the floor 3
From the Congressional Record: each member’s own words.
-
Mr. Speaker, I rise today in strong support of H.R. 2004, led by the gentleman from California (Mr. Lieu) and the gentleman from Ohio (Mr. Latta). Tyler's Law is named after Tyler Shamash, who suffered from a fatal fentanyl poisoning after doctors did not test for fentanyl when he was admitted to…
-
Mr. Speaker, I rise to speak in support of H.R. 2004, Tyler's Law. This legislation directs the Secretary of Health and Human Services to study the use of fentanyl testing in hospital emergency departments for patients experiencing an overdose. As we heard so eloquently from Chairman Guthrie, I,…
-
Mr. Speaker, I rise in support of H.R. 2004, Tyler's Law. This bill requires the Department of Health and Human Services to conduct a study and then to issue guidance to hospitals to test for fentanyl in emergency room screenings. This may come as a surprise to many. Right now many hospitals do not…
In releases and posts 3
-
Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, issued the following statement following the House passage of three Committee-led bills to combat the manufacturing of illicit drugs and to protect…
“I am glad to see the House take action to pass three House Energy and Commerce bills to build upon our work of combating illicit drugs that have devastated communities across our nation, especially here in Kentucky.”
-
Today, the U.S. House of Representatives passed a series of measures to protect American communities from public health threats.
“As Chairman of the Health Subcommittee, I am proud to have advanced these measures that target severe public health threats.”
-
Rep. Gabe Vasquez Champions Bipartisan Solutions to Protect New Mexicans From Fentanyl Crisis
On July 2, 2026, U.S. Representative Gabe Vasquez (NM-02) championed two bipartisan bills to protect New Mexicans from the fentanyl crisis, Tyler’s Law (H.R. 2004) and Sammy’s Law (H.R. 2657).
“Fentanyl is cutting too many lives short, ripping apart New Mexico families. We need to attack this crisis from every angle: stopping traffickers at the border, holding federal officials accountable when they fail our communities, giving parents tools to keep their kids safe online, and helping hospitals identify…”